- Home
- GENI vs PAHC Comparison
GENI vs PAHC Comparison
Compare GENI & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENI | PAHC |
|---|---|---|
| Founded | 2016 | 1946 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GENI | PAHC |
|---|---|---|
| Price | $5.20 | $51.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 3 |
| Target Price | $13.19 | ★ $34.33 |
| AVG Volume (30 Days) | ★ 5.9M | 215.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | $29.73 | $17.03 |
| Revenue Next Year | $28.38 | $3.82 |
| P/E Ratio | ★ N/A | $37.49 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $4.96 | $16.16 |
| 52 Week High | $13.73 | $56.30 |
Technical Indicators
Market Signals| Indicator | GENI | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 55.46 |
| Support Level | N/A | $49.74 |
| Resistance Level | $6.75 | $56.14 |
| Average True Range (ATR) | 0.43 | 2.22 |
| MACD | 0.05 | -0.59 |
| Stochastic Oscillator | 12.86 | 52.07 |
Price Performance
Historical ComparisonAbout GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.